Literature DB >> 18052873

Presence of lupus anticoagulant in an asymptomatic Nigerian.

Edeghonghon E Olayemi1, Godwin N Bazuaye.   

Abstract

BACKGROUND: The lupus anticoagulant (LA) is one of the antiphospholipid antibodies (aPL), which prolong phospholipid- dependent coagulation tests by interfering with coagulation reactions that depend on protein - phospholipid complexes in vitro.
METHOD: A 25 year old 'healthy' male Nigerian was screened for the presence of any coagulation abnormality using the KCT, PT and platelet count; after volunteering for his plasma to be used in the preparation of normal pooled plasma in a study.
RESULTS: He was discovered to have a prolonged KCT, PT and normal platelet count. Based on the prolonged KCT his plasma was subjected to mixing studies with various concentration of normal pooled plasma; the KCT index was calculated and a curve was plotted. His KCT index was 1.6 and the curve convex in the left axis suggesting the presence of LA. His past medical history and physical examination were not remarkable. Three months after the initial study, a repeat KCT index was 1.4 and the subject asymptomatic.
CONCLUSION: From literature review this is the first report of LA in an asymptomatic adult Nigerian; the importance of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052873      PMCID: PMC2269716          DOI: 10.5555/afhs.2007.7.3.182

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  16 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 2.  Epidemiology of the antiphospholipid antibody syndrome.

Authors:  M Petri
Journal:  J Autoimmun       Date:  2000-09       Impact factor: 7.094

3.  Lupus anticoagulant in Nigerian women with preeclampsia.

Authors:  O A Awodu; W A Shokunbi; O A Ejele
Journal:  West Afr J Med       Date:  2003-09

4.  Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria.

Authors:  O A Awodu; O A Ejele; W A Shokunbi; M E Enosolease
Journal:  Niger Postgrad Med J       Date:  2003-03

5.  Comparison of two simple tests for the lupus anticoagulant.

Authors:  T Exner
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

6.  [Clinical manifestations associated with the presence of lupus anticoagulant].

Authors:  L Miori; M Bellosta; E Miori; G Rabbiosi
Journal:  G Ital Dermatol Venereol       Date:  1989-03       Impact factor: 2.011

7.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

Review 8.  Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.

Authors:  Joab Chapman; Yehuda Shoenfeld
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 9.  Antiphospholipid antibodies in pediatrics.

Authors:  Ana I Quintero-Del-Rio
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

10.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

View more
  1 in total

1.  From HIV AIDS, TB to H. pylori and other infections in Africa.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.